Personlized Products Cb-03-1 - GnRH Antagonist Used for Peptides Synthesis – Gentolex
Personlized Products Cb-03-1 - GnRH Antagonist Used for Peptides Synthesis – Gentolex Detail:
Product Detail
|
NO |
Products |
CAS No. |
Application |
Key Quality Indicator |
||||
|
Purity |
Isomer |
Specific impurity |
*Max1 |
Moisture |
||||
|
1 |
Fmoc-3-(2-naphthyl)-D-Ala-OH |
138774-94-4 |
Most products |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
2 |
Ac-3-(2-naphthyl)-D-Ala-OH |
37440-01-0 |
Most products |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
3 |
Fmoc-3-(3-pyridinyl)-D-Ala-OH |
142994-45-4 |
Most products |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
4 |
Fmoc-4-chloro-D-Phe-OH |
142994-19-2 |
Most products |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
5 |
Fmoc-D-Cit-OH |
200344-33-8 |
Cetrorelix |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤1.0% |
|
6 |
Fmoc-D-Ala-OH.H2O |
79990-15-1 |
Most products |
≥99.5% |
≤0.1% |
≤0.1% |
≤0.2% |
≤6.5% |
|
7 |
Fmoc-D-Aph(tBuCbm)-OH |
1433975-21-3 |
Degarelix |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
8 |
Fmoc-D-Aph(Cbm)-OH |
324017-22-3 |
Degarelix |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
9 |
Fmoc-L-Aph(L-Hor)-OH |
1253282-31-3 |
Degarelix |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
10 |
Fmoc-L-Lys(iPr,Boc)-OH |
201003-48-7 |
Degarelix |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
11 |
Fmoc-N-Me-Tyr(tBu)-OH |
133373-24-7 |
Abarelix |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
12 |
Fmoc-D-Asn(Trt)-OH |
180570-71-2 |
Abarelix |
≥99.0% |
≤0.2% |
≤0.3% |
≤0.3% |
≤1.0% |
|
13 |
Fmoc-HomoArg(Et)2-OH.HCl |
1864003-26-8 |
Ganirelix |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤2.0% |
|
14 |
Fmoc-D-HomoArg(Et)2-OH.HCl |
2098497-24-4 |
Ganirelix |
≥95.0% |
≤0.5% |
≤1.0% |
≤2.0% |
≤2.0% |
|
15 |
Fmoc-Lys(nicotinoyl)-OH |
252049-11-9 |
Antide |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
|
16 |
Fmoc-D-Lys(nicotinoyl)-OH |
252049-12-0 |
Antide |
≥98.0% |
≤0.2% |
≤0.3% |
≤0.5% |
≤1.0% |
* Max1 = Max Unknown Impurity
Other Indicator:
- Acetic Acid: ≤0.02% (All Products)
- Ethyl Acetate: ≤0.5% (All Products)
- Alcohol: ≤0.5% (All Products)
TOC and Conductivity
TOC and conductivity of main supply and return points are monitored periodically. TOC is monitored by QC on every week. Conductivity is monitored online and recorded by purified water station operator once every four hours. The conductivity is monitored at the primary RO, secondary RO, EDI and total return point of distribution system. The specification of purified water is in place and conforms to pre-defined specification which no more than 1.3 µs/cm at 25°C (USP). For main supply and return points, full test. is performed every week, for other using point in the circulating loop, full test is performed once every month. The full test includes characters, pH, nitrate, nitrite, ammonia, conductivity, TOC, non-volatile substances, heavy metals, microbial limits and bacterial endotoxin.
Product detail pictures:
Related Product Guide:
Our primary objective is usually to offer our shoppers a serious and responsible small business relationship, offering personalized attention to all of them for Personlized Products Cb-03-1 - GnRH Antagonist Used for Peptides Synthesis – Gentolex , The product will supply to all over the world, such as: Cyprus, Netherlands, Singapore, Upon today, we have customers from all over the world, including USA, Russia, Spain, Italy, Singapore, Malaysia, Thailand, Poland, Iran and Iraq. The mission of our company is to provide the highest quality products with best price. We are looking forward to doing business with you!
By Eunice from Finland - 2017.09.16 13:44
The sales manager is very patient, we communicated about three days before we decided to cooperate, finally, we are very satisfied with this cooperation!
By Adam from Bolivia - 2017.12.09 14:01
